Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism OX2R agonists(Orexin receptor type 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Narcolepsy | Preclinical | US | 28 Jun 2024 | |
Central Nervous System Diseases | Preclinical | US | 01 Dec 2023 | |
Central Nervous System Diseases | Preclinical | CH | 01 Dec 2023 |